Education
About Us
Working with TipRanks
Follow Us
Telesis Bio (TBIO)
OTHER OTC:TBIO
TBIO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $3.95
Previous CloseN/A
Volume413.00
Average Volume (3M)254.00
Market Cap
$870.17K
Enterprise Value$49.56M
Total Cash (Recent Filing)$4.51M
Total Debt (Recent Filing)$16.29M
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Aug 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding78,393,530
10 Day Avg. Volume721
30 Day Avg. Volume254
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap56.96
Enterprise Value/Revenue3.66
Enterprise Value/Gross Profit10.83
Enterprise Value/Ebitda-1.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Telesis Bio News
TBIO FAQ
What was Telesis Bio’s price range in the past 12 months?
Telesis Bio lowest stock price was $0.01 and its highest was $3.95 in the past 12 months.
What is Telesis Bio’s market cap?
Telesis Bio’s market cap is $870.17K.
When is Telesis Bio’s upcoming earnings report date?
Telesis Bio’s upcoming earnings report date is Aug 12, 2025 which is 48 days ago.
How were Telesis Bio’s earnings last quarter?
Currently, no data Available
Is Telesis Bio overvalued?
According to Wall Street analysts Telesis Bio’s price is currently Overvalued.
Does Telesis Bio pay dividends?
Telesis Bio does not currently pay dividends.
What is Telesis Bio’s EPS estimate?
Telesis Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telesis Bio have?
Telesis Bio has 78,393,530 shares outstanding.
What happened to Telesis Bio’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Telesis Bio?
Among the largest hedge funds holding Telesis Bio’s share is Woodline Partners LP. It holds Telesis Bio’s shares valued at 0.
Company Description
Telesis Bio
Telesis Bio, Inc. is a biotechnology company that operates in the life sciences sector. The company specializes in providing solutions for synthetic biology and DNA synthesis. Telesis Bio's core products and services include advanced DNA synthesis technologies that enable researchers and scientists to create synthetic DNA and RNA for various applications in research, therapeutics, and industrial biotechnology.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---